> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Epidermolysis Bullosa Drugs
- URL: https://www.fdaweb.com/draft-guide-on-epidermolysis-bullosa-drugs/
- Published: 2018-06-18T12:00:00.000Z
- Updated: 2026-09-15T00:13:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141707

*Federal Register* notice: FDA has made available a draft guidance entitled “Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Manifestations.” The document notes that there is an unmet medical need among EB patients due to the paucity of effective treatment options. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-06-18/pdf/2018-12976.pdf?ref=fdaweb.com).